Skip to content
Insurance, Medical Health Aged Care

Early hay fever season prompts urgent doctor health warning

September 16, 2024 2 mins read

Doctors are warning Australians not to ignore hay fever symptoms as the allergy season arrives this year.

 

Bupa Clinical Director Dr Tony MacDermott said the caution was most important for asthmatics, as most people with asthma were also susceptible to hay fever.

 

Hay fever affects about 1 in 5 Australians, which can be triggered by pollen during weather changes at this time of year in many parts of Australia, and certain allergens like smoke throughout the year.

 

Dr MacDermott said doctors were expecting an increase in people presenting with hay fever, which typically peaks during spring and summer.

 

“While for some people hay fever may just be itchy eyes and sneezing, letting it go untreated can lead to ear infections in children, sinus infection in adults and can also flare up asthma,” he said.

 

Dr MacDermott said it could be difficult at times to tell the difference between asthma and hay fever, and encouraged people with symptoms to consult their GP, or a specialised allergy clinic.

 

“If you’re wheezing or experiencing shortness of breath or a persistent cough, don’t let that go unchecked as they’re not typical hay fever symptoms and may be signs of seasonal asthma,” he said.

 

“During spring, grass pollen can be spread across large distances by weather events such as thunderstorms, which may exasperate hay fever and worsen asthma. Asthma can lead to hospitalisation or even become deadly if it’s left untreated.”

 

Typical hay fever symptoms include sneezing, coughing, runny or blocked nose, itchy, red, or watery eyes and an itchy throat. Common asthma symptoms include wheezing, chest tightness, coughing, sweating, faintness and shortness of breath.

 

Dr MacDermott said prevention was key to best manage hay fever and asthma.

 

“If you suffer from asthma, now is a good time to ensure your inhaler is not past its expiry date and not empty,” he said.

 

“Prevention is the best way to manage asthma and helps take pressure off ambulances and overcrowded public hospitals.”

 

ENDS

Note to News Desks

 

Interviews available with Dr Tony MacDermott

 

For more information, please contact:
Aleks Devic                                                    
Head of Media (Health Insurance) and Content, Bupa                             
Email:
aleks.devic@bupa.com.au     

Mob: 0412 868 933                                                      

 

About Bupa Asia Pacific

Bupa is an international healthcare group which has been committed to a purpose of helping people live longer, healthier, happier lives and making a better world for more than 70 years.

Bupa Asia Pacific operates in Australia, New Zealand and Hong Kong, supporting about 7.3 million customers through a broad range of health and care services including health insurance, aged care, dental, medical, optical and hearing services.

Employing more than 22,000 people in the region, we believe that we can make a real difference to the lives of customers through our values, purpose and the way that we deliver personalised care.

Over the past 17+ years we have invested more than AUD$36 million in partnerships and programs focused on improving health of communities across Australia.



 

 

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.